ArticleNeuropsychiatric disease and treatment2019

CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients.

You-Ting Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.